BAILLY R JEFFREY sold $5.0M of UFPT (indirect holdings)

BAILLY R JEFFREY (Executive Chairman) sold 15,695 indirectly-held shares of UFP TECHNOLOGIES INC (UFPT) at an average of $318.38 ($315.06–$320.05, $5.00M total) across 4 trades over 2026-08-06 to 2026-08-07.

Original reporting
SEC EDGAR · BAILLY R JEFFREY
Published Aug 10, 2026, 10:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 10, 2026, 10:53 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$UFPT
Neutral
medium confidence
Mentioned
$UFPT
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$UFPTNeutralLow
01

Why it matters

A $5.0M open-market sale by a top insider can influence short-term sentiment, but the disclosure alone does not provide new operational or financial information.

02

Market read

Traders may monitor whether additional insider selling follows, but there is no direct fundamental catalyst in the text.

03

What to watch

The filing notes indirect holdings and does not specify the reason for sale; without context (taxes, diversification, estate planning), interpreting it as bearish is speculative.

Relevance 6/10Novelty 5/10Timing: filed after-hours on 2026-08-10, reflecting trades dated 2026-08-06 to 2026-08-07

Background

This is a Form 4 insider transaction disclosure for UFP Technologies, reported by executive chairman Bailly R. Jeffrey.

Company-level read

Ticker impact

$UFPTNeutralMedium confidence
Context

UFP Technologies executive chairman sold about $5.0M of UFPT shares in open-market trades at $315.06 to $320.05 per share.

Expected impact

Likely limited, sentiment-driven pressure or no sustained impact unless follow-on selling continues.

Evidence & confidence

Form 4 shows an open-market sale with no 10b5-1 plan stated, but the article provides no new company performance, guidance, or regulatory development.

Market effects

No sector-level signal is provided beyond a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

The sale could be routine liquidity planning and may not reflect negative views on the business, especially given multiple small lots across two days.

Key entities

  • UFP Technologies Inc

    Company whose shares were sold by the executive chairman in open-market transactions.

  • Bailly R. Jeffrey

    Executive chairman and reporting person who sold shares via open-market sale transactions.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$UFPTMed

UFP Technologies (UFPT) Shares Just Moved, So What Is Driving Attention Now?

UFP Technologies (UFPT) reported Q3 sales of $172.43M and net income of $20.62M, up from the previous year. Shares rose 17.66% to $329.82 on the news, extending a 15.32% 7-day return. Analysts see a fair value of $355, citing growth in medical device components and packaging. However, UFPT trades at 33.4x earnings, higher than the industry average of 23.9x, raising valuation concerns.

$UFPTMed

UFP Technologies (UFPT) Q3 2026 Earnings Call Transcript

UFP Technologies (UFPT) reported Q3 2026 sales up 11.6%, with organic growth at 11.1%. Gross margin improved to 29.4% from 27.7% last year. Adjusted EPS was $2.88, up significantly. The company is investing in growth, including acquisitions like CI Medical, and expanding credit facilities. AJR operations are behind schedule but expected to improve in 2027. Management remains optimistic about long-term growth and shareholder value.

$UFPTHighAI 8/10

UFP Technologies (NASDAQ:UFPT) delivers impressive Q3 2026

UFP Technologies (UFPT) reported Q3 2026 revenue of $172.4M, up 11.6% YoY and 3.2% above estimates. Adjusted EPS of $2.88 beat estimates by 7.3%. Operating margin held steady at 16%. The company cited operational improvements and growth in new programs. Analysts expect 5.6% revenue growth over the next 12 months.

$UFPTHigh

UFP Technologies Announces Strong Q3 Results

UFP TECHNOLOGIES INC (UFPT) filed an SEC Form 8-K — Results of Operations and Financial Condition. UFP Technologies Announces Strong Q3 Results Newburyport, Mass., November 3, 2026. UFP Technologies, Inc. (Nasdaq: UFPT), a trusted contract development and manufacturing organization specializing in comprehensive solutions for medical devices, sterile packaging and other highly